BOOSTING ADHERENCE TO REDUCE GLP-1 WASTAGE Noom help members surmount the challenges that come with adhering to GLP-1 therapy, allowing them to maximize its benefits
Biermanns study found that most people who halved the dosing frequency of a GLP-1 medication maintained their weight loss and improvements in blood sugar, cholesterol, and blood pressure
Value cost savings over FDA-approval of finished product: If you understand the difference between FDA-approved and compounded medications, recognize that compounded versions haven't undergone the same regulatory review process, and prioritize affordability when insurance doesn't cover GLP-1s for weight loss, Yucca Health's compounded formulations offer significant cost savings
What is the Expected Future
A patient on 2.4 mg of semaglutide weekly might reduce to 1.0 mg or even 0.5 mg for maintenance
Most current compounds target only one or two of these receptors